viewCollagen Solutions PLC

Collagen Solutions focusing on commercial development

Jamal Rushdy, the newly appointed chief executive of Collagen Solutions PLC (LON:COS), says the company has “a pretty clear vision of going into the regenerative materials space” which will be achieved through the alignment of component companies plus  “great technologies, great market space, great teams.”

The medical technology specialist has been created through three legacy businesses, and Rushdy says future commercial development will be achieved by building sales and marketing teams in country, in a number of regions instead of responding to enquiries and relying on word of mouth.

China is a long term ambition of the company which is developing a small collagen based plug used in arthroscopic orthopaedic surgery to treat certain cases of osteoarthritis.

Currently, Rushdy says the greatest growth potential is seen in Collagen’s existing market in South Korea and "we’ve barely touched some of the other countries in Asia Pacific that we see some opportunity for growth as well.”

Quick facts: Collagen Solutions PLC

Price: 6.625 GBX

Market: LSE
Market Cap: £30.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...


Morning Report: Vaccines and EU package lift FTSE 100

Headlines from the Proactive UK newsroom. The FTSE 100 was in better heart as yesterday’s vaccine news and €750bn EU bail-out package helped sentiment. The blue-chip index rose 43 points to 6,305. Grocery tills were their busiest ever over the past 12 weeks according to market research...

on 21/7/20

2 min read